{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T06:13:57Z","timestamp":1778825637312,"version":"3.51.4"},"reference-count":15,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000015","name":"Canadian Cancer Society Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000015","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.brachy.2019.06.007","type":"journal-article","created":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T08:38:31Z","timestamp":1566290311000},"page":"787-792","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["The association of intraprostatic calcifications and dosimetry parameters with biochemical control after permanent prostate implant"],"prefix":"10.1016","volume":"18","author":[{"given":"Eric","family":"Vigneault","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khaly","family":"Mbodji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damien","family":"Carignan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9-Guy","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nelson","family":"Miksys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rowan M.","family":"Thomson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylviane","family":"Aubin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Varfalvy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc","family":"Beaulieu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2019.06.007_bib1","first-page":"1","article-title":"EAU- ESTRO - SIOG guidelines on prostate cancer","author":"Mottet","year":"2016","journal-title":"Eur Assoc Urol"},{"key":"10.1016\/j.brachy.2019.06.007_bib2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.brachy.2011.12.006","article-title":"ABS brachytherapy consensus guidelines","volume":"11","author":"Horwitz","year":"2012","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2019.06.007_bib3","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1118\/1.598440","article-title":"Correlation of medical dosimetry quality indicators to the local tumor control in patients with prostate cancer treated with iodine-125 interstitial implants","volume":"25","author":"Nath","year":"1998","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2019.06.007_bib4","doi-asserted-by":"crossref","first-page":"6208","DOI":"10.1118\/1.4747264","article-title":"Report of the Task Group 186 on model-based dose calculation methods in brachytherapy beyond the TG-43 formalism: current status and recommendations for clinical implementation","volume":"39","author":"Beaulieu","year":"2012","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2019.06.007_bib5","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1118\/1.597458","article-title":"Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM radiation\u00a0Therapy Committee Task group No. 43. American association of Physicists in Medicine","volume":"22","author":"Nath","year":"1995","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2019.06.007_bib6","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1118\/1.1646040","article-title":"Update of AAPM Task Group No. 43 Report: a revised AAPM protocol for brachytherapy dose calculations","volume":"31","author":"Rivard","year":"2004","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2019.06.007_bib7","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.ijrobp.2016.11.025","article-title":"Large-scale retrospective Monte Carlo dosimetric study for permanent implant prostate\u00a0brachytherapy","volume":"97","author":"Miksys","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2019.06.007_bib8","doi-asserted-by":"crossref","first-page":"4329","DOI":"10.1002\/mp.12306","article-title":"Coupling I-125 permanent implant prostate brachytherapy Monte Carlo dose calculations with radiobiological models","volume":"44","author":"Miksys","year":"2017","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2019.06.007_bib9","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1088\/0031-9155\/61\/7\/2705","article-title":"Patient-specific Monte Carlo dose calculations for (103)Pd breast brachytherapy","volume":"61","author":"Miksys","year":"2016","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.brachy.2019.06.007_bib10","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.radonc.2015.01.014","article-title":"Calcifications in low-dose rate prostate seed brachytherapy treatment: post-planning dosimetry and predictive factors","volume":"114","author":"Collins Fekete","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2019.06.007_bib11","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1118\/1.2400843","article-title":"Benchmarking BrachyDose: voxel based EGSnrc Monte Carlo calculations of TG-43 dosimetry parameters","volume":"34","author":"Taylor","year":"2007","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2019.06.007_bib12","doi-asserted-by":"crossref","first-page":"3910","DOI":"10.1118\/1.3476217","article-title":"Fast Monte Carlo dose calculations for brachytherapy with BrachyDose","volume":"37","author":"Thomson","year":"2010","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2019.06.007_bib13","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.anndiagpath.2007.07.001","article-title":"Calcifications in prostate and ejaculatory system: a study on 298 consecutive whole mount sections of prostate from radical prostatectomy or cystoprostatectomy specimens","volume":"12","author":"Suh","year":"2008","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.brachy.2019.06.007_bib14","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.radonc.2013.10.028","article-title":"Cold spot mapping inferred from MRI at time of failure predicts biopsy-proven local failure after permanent seed brachytherapy in prostate cancer patients: implications for focal salvage brachytherapy","volume":"109","author":"Crehange","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2019.06.007_bib15","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.urology.2014.09.026","article-title":"Prevalence of prostatic calcification subtypes and association with prostate cancer","volume":"85","author":"Smolski","year":"2015","journal-title":"Urology"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472118307700?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472118307700?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:14:41Z","timestamp":1761531281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472118307700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S1538472118307700"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2019.06.007","relation":{},"ISSN":["1538-4721"],"issn-type":[{"value":"1538-4721","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The association of intraprostatic calcifications and dosimetry parameters with biochemical control after permanent prostate implant","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2019.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}